At Astera Cancer Care, we are dedicated to not only advancing our cancer research but also providing our patients with the most cutting-edge treatments available. These treatments often come through our clinical trials.
What do Clinical Trials do?
Clinical trials at Astera study new drugs, new surgical methods, new ways to administer treatments, and behavioral changes that will extend people's life spans. Clinical trials often help doctors find better treatment options, and at Astera, we are committed to finding the best treatments for our patients.
At Astera, clinical trials are conducted in phases, and you can often only be a part of one phase of the study.
What are the Phases of a Clinical Trial?
- Phase I: Test if a new treatment is safe and look for the best way to administer it. Doctors also look for signs that the cancer responds to the new treatment.
- Phase II: Test if one type of cancer responds to the new treatment.
- Phase III: Test if a new treatment is better than a standard treatment.
- Phase IV: Find more information about long-term benefits and side effects.
If you are interested in joining a clinical trial, talk to your doctor. Not all clinical trials are right for all patients. They often involve strict protocols that your doctor will have to follow.
At Astera Cancer Care, we are always working on new clinical trials. Right now, one of our clinical trials focused on lung cancer is called IDeate-Lung02. This trial studies Ifinatamab deruxtecan versus treatment of a physician's choice in subjects with relapsed small cell lung cancer. In this trial, our doctors are assessing whether treatment with I-DXd improves objective response rate (ORR) and prolongs overall survival.
If you have any questions regarding clinical trials or would like to participate in any of our clinical trials, please talk to your doctor.